Teva CEO Richard Francis Talks Tariffs, Generic Drugs Market
Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.
See omnystudio.com/listener for privacy information.
You May Also Like
HOGENT: kwaliteit dus!
The Podcast Planet
Datasets
Visionary
CFO Podcast
Peter De Roeck
Stock Movers
iHeartPodcasts
🇨🇭🇩🇪 Markt-Trends setzen mit Swissquote
Markus Koch, Wieland Arlt und Feyyaz Alingan bieten Ihnen einen Überblick über alle Anlageklassen
Marketplace All-in-One
Marketplace
Marketplace Morning Report
Marketplace
Thoughtful Money with Adam Taggart
Adam Taggart | Thoughtful Money
LAMBS TO LIONS
Matt Funk
The Lucy Ann Lance Show
Cumulus Media Detroit
HOGENT: kwaliteit dus!
The Podcast Planet
Datasets
Visionary
CFO Podcast
Peter De Roeck
Stock Movers
iHeartPodcasts
🇨🇭🇩🇪 Markt-Trends setzen mit Swissquote
Markus Koch, Wieland Arlt und Feyyaz Alingan bieten Ihnen einen Überblick über alle Anlageklassen
Marketplace All-in-One
Marketplace
Marketplace Morning Report
Marketplace
Thoughtful Money with Adam Taggart
Adam Taggart | Thoughtful Money
LAMBS TO LIONS
Matt Funk
The Lucy Ann Lance Show
Cumulus Media Detroit
Community discussion